Clinical Trials Sponsored by Barretos Cancer Hospital

Total 9712 results

Zhejiang Cancer Hospital

Unknown

Abraxane Combined With Xeloda as Neo-Adjuvant Chemotherapy in Early Breast Cancer

Breast Cancer
Zhejiang Cancer Hospital

Unknown

A Research About Nutrition Impact for Local Advanced Nasopharyngeal Carcinoma Patients

Malignant Neoplasm of Nasopharynx

China
Fujian Cancer Hospital

Unknown

Study of the Combination of Apatinib and POF

Gastric Adenocarcinoma

China
Zhejiang Cancer Hospital

Unknown

Predictor Analysis of Acute Radiation Oral Mucositis in NPC Patients Treated With IMRT/TOMO Combined Chemotherapy

Nasopharyngeal Carcinoma

China
Zhejiang Cancer Hospital

Unknown

TOMO Versus IMRT in Nasopharyngeal Carcinoma Patients

Nasopharyngeal Carcinoma

China
Fujian Cancer Hospital

Unknown

Phase I Study of the Combination of Anlotinib With Pemetrexed or Docetaxel

Non-squamous Non-small Cell Lung Cancer
Fujian Cancer Hospital

Unknown

Appaconitine Patch for Oral Mucositis Pain Caused by Chemoradiotherapy in Patients With Nasopharyngeal Cancer

Radiation Induced Oral Mucositis

China
Fujian Cancer Hospital

Unknown

Gefitinib and Berberine in the First-line Treatment of Lung Adenocarcinoma With EGFR Mutation (Geber)

Lung Adenocarcinoma | EGFR Mutation

China
Henan Cancer Hospital

Unknown

The FLOT Regimen Conversion Therapy of Adenocarcinoma of the Stomach / Gastroesophageal

Adenocarcinoma of the Stomach / Gastroesophageal

China
Zhejiang Cancer Hospital

Unknown

Hippocampus Avoidance During Intensity Modulated Radiotherapy for T4 Nasopharyngeal Carcinoma Patients

Nasopharyngeal Carcinoma

China
Zhejiang Cancer Hospital

Unknown

Aromatase Inhibitors Plus Chemotherapy vs Chemotherapy as Neoadjuvant Treatment in Postmenopausal HR(+) Breast Cancer (ACCN)

Neoadjuvant Therapy

China
Fujian Cancer Hospital

Unknown

EGFR Mutation Positive NSCLC Patients With Gefitinib and Thalidomide

Chemotherapy Effect | NSCLC Stage IV

China
Zhejiang Cancer Hospital

Completed

DEB-TACE Treatment in 367 Liver Cancer Patients

Liver Cancer
Fujian Cancer Hospital

Unknown

Next-generation Sequencing of Small Cell Lung Cancer to Identify Susceptibility Gene and to Assess Treatment

SCLC
Zhejiang Cancer Hospital

Unknown

Chemotherapy Plus Radiation Therapy in Treating Patients With Primary Stage IVB Cervical Cancer

Cervical Cancer Stage IVB

China
Zhejiang Cancer Hospital

Unknown

Docetaxel 2-weeks Regimen in the Treatment of HER2 Negative Metastatic Breast Cancer

Breast Cancer

China
Fujian Cancer Hospital

Unknown

Docetaxel and S-1 Combination Therapy as Second-line Treatment for Advanced Gastric Cancer

Advanced Gastric Cancer

China
Fujian Cancer Hospital

Unknown

Clinical Trial to Compare Apatinib Plus Irinotecan Versus Single Irinotecan as Second-line Treatment in AGC or EGJA

Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction

China
Ningbo Cancer Hospital

Unknown

PD-1 Antibody Expressing CAR T Cells for Mesothelin Positive Advanced Malignancies

Advanced Cancer | Solid Tumor, Adult

China
Ningbo Cancer Hospital

Unknown

Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer

Chemotherapy | Advanced Gastric Cancer | Precision Cell Immunotherapy

China
Fujian Cancer Hospital

Unknown

EGFR-TKIs Combine Chemotherapy as First-line Therapy for Patients With Advanced EGFR Mutation-positive NSCLC (effect)

EGFR Gene Mutation
Hangzhou Cancer Hospital

Unknown

Apatinib for Metastatic Esophageal Cancer.

Esophageal Cancer | Apatinib | Metastatic Esophageal Cancer

China
Hangzhou Cancer Hospital

Unknown

RT Plus EGFR-TKI for Wild-type NSCLC

Non-small Cell Lung Cancer | Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI)

China
Hangzhou Cancer Hospital

Completed

CCRT for Esophageal Cancer.

Esophageal Cancer | Paclitaxel | Concurrent Chemoradiotherapy | Oxaliplatin
Zhejiang Cancer Hospital

Unknown

A Phase III Trail of Adjuvant Chemoradiotherapy Versus Adjuvant Radiotherapy in Esophageal Squamous Cell Carcinoma

Esophageal Cancer

China
Zhejiang Cancer Hospital

Unknown

HIPEC, Intravenous Chemotherapy and Surgery for the Treatment of Advanced GC With Peritoneal Metastasis

Gastric Cancer

China
Fujian Cancer Hospital

Unknown

Comparison of Short Term Outcomes Between Totally Laparoscopic and Laparoscopy-Assisted Distal Gastrectomy With Billroth-II Reconstruction and D2 Lymphadenectomy for Locally Advanced Gastric Cancer

Locally Advanced Gastric Cancer | Total Laparoscopic Distal Gastrectomy
Zhejiang Cancer Hospital

Unknown

Endostar Combination With Chemotherapy for the Metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Zhejiang Cancer Hospital

Unknown

Comparable Study of Different Radiation Dose in Esophageal Carcinoma

Esophageal Carcinoma

China
Zhejiang Cancer Hospital

Unknown

Phase II Trial of Regimen for Stage III (N2) NSCLC Using Induction Treatment Followed by Resection (ZTOG-1202)

Non-small Cell Lung Cancer Stage IIIA

China
Zhejiang Cancer Hospital

Unknown

Neoadjuvant Versus Adjuvant Therapy in Treating Resectable Thoracic Esophageal Cancer

Esophageal Cancer

China
Zhejiang Cancer Hospital

Unknown

Endostar Combined With mFOLFOX6 for First-line Treatment of Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

China
Zhejiang Cancer Hospital

Unknown

Study of Relationship Between UGT1A1 Gene Polymorphism and Toxicity and Efficacy of Irinotecan in Small Cell Lung Cancer

Small Cell Carcinoma of Lung

China
Zhejiang Cancer Hospital

Unknown

Peri-operative Chemotherapy With ECX or XP in the Treatment of Advanced Gastric Cancer

Gastric Cancer

China
Theagenio Cancer Hospital

Unknown

Cisplatin Chemoradiation With or Without Cetuximab for Locoregionally Advanced Squamous Cell Carcinomas (SCC) of the Head and Neck

Head and Neck Neoplasms | AJCC Stage III/IV

Greece
Zhejiang Cancer Hospital

Unknown

Gefitinib Combined With Radiotherapy in Elderly Patients With Esophageal Cancer

Esophageal Cancer

China
Zhejiang Cancer Hospital

Unknown

Prophylactic Cranial Irradiation in Erlotinib/Gefitinib-responders With Non-small Cell Lung Cancer (NSCLC) (RT1001)

Non-small Cell Lung Cancer

China
Zhejiang Cancer Hospital

Unknown

Erlotinib Combined With Radiotherapy in Patients With Non-resectable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC) (RT0901)

Non-small Cell Lung Cancer

China
Taian Cancer Hospital

Unknown

Study of Lobaplatin，5-Fluorouracil and Leucovorin for the Treatment of Esophageal Carcinoma

Esophageal Carcinoma

China
Memorial Sloan Kettering Cancer Center
University of Michigan; Queens Cancer Center of Queens Hospital

Completed

Intermittent High-Dose Lapatinib in Tandem With Capecitabine for HER2 Overexpressed/Amplified Metastatic Breast Cancer With Central Nervous System (CNS) Metastases

Metastatic Breast Cancer | Central Nervous System (CNS) Metastases

United States
Hubei Cancer Hospital

Not yet recruiting

SBRT, Chemotherapy, and AK112 Neoadjuvant Therapy for Triple-negative Breast Cancer (TNBC)

Breast Cancer
Fujian Cancer Hospital

Not yet recruiting

The Efficacy and Safety of Tislelizumab Combined With Anlotinib and S1 Plus Oxaliplatin as Neoadjuvant Therapy for the Locally Advanced Adenocarcinoma of Esophagogastric Junction

Immunotherapy Gastroesophageal Junction

China
Hunan Cancer Hospital

Recruiting

Utidelone (UTD1) Plus Capecitabine in Non-pCR TNBC After Neoadjuvant Therapy

Triple Negative Breast Neoplasms

China
Henan Cancer Hospital

Not yet recruiting

PD1 Antibody Combined With mFOLFOX6 Neoadjuvant Therapy for Advanced Resectable Metastatic Colon Cancer

Metastatic Colon Cancer
Hunan Cancer Hospital

Not yet recruiting

Cadonilimab in Combination With Anlotinib in the Treatment of Locally Progressive or Metastatic Melanoma With First-Line Therapy Failure

Melanoma
Hunan Cancer Hospital

Recruiting

Sequencing-based Counting of Plasma Epstein-Barr Virus DNA in Non-metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma | Herpesvirus 4, Human

China
Zhejiang Cancer Hospital

Recruiting

Genotype-driven Weekly Irinotecan Liposomes in Combination With Capecitabine-based Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer

Rectal Cancer

China
Henan Cancer Hospital

Recruiting

TAS-102 Combined With Bevacizumab for Second-line Maintenance Treatment of Advanced Colorectal Cancer

Colorectal Cancer

China
Zhejiang Cancer Hospital

Not yet recruiting

Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma in the Era of Immunotherapy

Adjuvant Radiotherapy

China
Zhejiang Cancer Hospital

Recruiting

Ciprofol EC50 for Inducing Loss of Consciousness in Elderly Patients

Elderly Patients

China

3

Subscribe